Connecticut Innovations

[Connecticut Innovations](http://www.ctinnovations.com) provides strategic capital and operational insight to to companies in high-tech industries such as energy, biotechnology, information technology, and photonics. Their mission is to be the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. By offering flexible financing, strategic guidance and introductions to valuable partners, Connecticut innovations enable promising businesses to thrive.

Matthew J. Archuleta

Senior Associate, Investments

Matthew Bloom

Director of Investments

Brian Dowd

Director, Investments

Konstantine Drakonakis

Managing Venture Partner

Drew D’Alelio

Senior Associate, Investments

Peter V. Longo

Senior Managing Director

Jordan Lue

Analyst, Investments

Matthew J. McCooe

CEO

Patrick O'Neill

Managing Director, Venture Capital Investments

Malik D. Okoro

Senior Associate, Investments

Matt Panicali

Associate, Investments

Danny Qiao

Associate, Investments

Roth, Douglas J.

Managing Director

Siuta, Philip

COO and CFO

Anil Vasagir

Director of Investments

Daniel Wagner

Senior Managing Director, Investments

Renee Wasko

Associate, Investments

Wurzer CPA, David M.

Executive Vice President and Chief Investment Officer

326 past transactions

Swanston Labs

Seed Round in 2025
Swanston Labs builds data-driven solutions aimed at disrupting the convergence of media, entertainment, technology, and commerce. The company focuses on leveraging innovative technologies to address the $7 trillion global leisure spending market. Swanston Labs operates under the Swanston Organization, which also includes Swanston Family Ventures and Swanston Philanthropy, collectively advancing the mission of innovation and inclusion.

Normunity

Series B in 2025
Normunity is a biotechnology company focused on developing precision immuno-oncology medicines, specifically a new class known as immune normalizers. These medicines aim to target novel mechanisms that enhance the body’s natural immune response against cancer. In collaboration with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is researching newly-discovered mechanisms of immune disruption in cancer, utilizing proprietary discovery platforms to explore the intricate interactions between cancer and the immune system. The company is advancing a pipeline of immune normalizers, which includes initial drug programs designed to address the exclusion of T-cells from immune-sensitive tumors and other factors that impede normal immune function in cancer. Normunity operates from locations in Boston, Massachusetts, and West Haven, Connecticut.

VeraDermics

Series B in 2024
VeraDermics is a dermatology company focused on developing innovative solutions for skin conditions, particularly warts. The company has created a dissolvable microneedle patch that delivers immunotherapy painlessly, stimulating the body's immune response to combat the wart virus. This patch is designed to be applied like a bandage and remains on the skin for less than an hour. During this time, the microneedles, made from immune stimulators embedded in a polymer matrix, dissolve and are implanted into the skin. After the adhesive backing is removed, the microneedles continue to dissolve over the following weeks, releasing immune stimulators directly into the wart. This method not only provides a pain-free treatment option but also simplifies the administration process for medical practitioners and enhances patient comfort.

Nimbus Power Systems

Pre Seed Round in 2024
Nimbus Power Systems focuses on creating a cleaner environment by designing and integrating zero-emission fuel cell systems specifically for heavy-duty markets. The company specializes in advanced cell technology, offering one-to-one replacements for diesel engines. Its innovative architecture enhances fuel cell performance and eliminates the need for a DC/DC converter. This enables clients to utilize hydrogen fuel cells that do not emit harmful pollutants, contributing to a sustainable energy future.

Crew Carbon

Seed Round in 2024
CREW Carbon focuses on the removal of greenhouse gas emissions from wastewater through engineered enhanced weathering. The company's technology harnesses the natural properties of minerals to effectively treat both municipal and industrial wastewater while permanently storing carbon dioxide. Operating in the environmental services sector, CREW Carbon is dedicated to greenhouse gas management and carbon removal, striving to contribute positively to environmental sustainability. Its innovative climate technology solutions are designed to assist businesses and governments in achieving their climate objectives.

GoodSAM

Series A in 2024
GoodSAM is a food and beverages company specializing in snack and food products made from natural ingredients. It operates a chocolate brand that focuses on manufacturing cocoa products derived from regenerative farming practices. The company offers a range of items, including coffee, nuts, fruits, and seeds, as well as a line of sugar-free, vegan, and keto-friendly chocolate products. This line features chocolate bars, chocolate chips, and chocolate-coated nuts that incorporate allulose, a natural low-calorie sweetener sourced from dates and figs. GoodSAM aims to provide healthy, sustainable, and farmer-friendly chocolate options to its customers.

ampUp

Series A in 2024
ampUp is a Silicon Valley-based company that specializes in electric vehicle (EV) charging solutions. It has developed a software platform that facilitates a reservable charging network, connecting drivers, hosts, and fleets to make EV charging more accessible and efficient. The platform allows businesses and property owners to manage multiple charging stations seamlessly, promoting a peer-to-peer network that enables users to monetize their chargers. By listing their charging stations on ampUp's network, customers can earn revenue while contributing to broader electrification efforts in their communities. Overall, ampUp aims to simplify the charging experience and support the growing demand for electric vehicle infrastructure.

Air Company

Series B in 2024
Air Company is a carbon utilization firm focused on transforming carbon dioxide (CO2) captured from the atmosphere into sustainable consumer and industrial products. Utilizing its patented Carbon Conversion Reactor, which mimics photosynthesis, the company effectively converts CO2, water, and renewable energy into carbon-negative alcohols and fuels. Among its product offerings are AIR Vodka, AIR Hand Sanitizer, and AIR Eau de Parfum. The company is also advancing the development of CO2-derived sustainable aviation fuel (SAF), which will be certified by recognized sustainability organizations. With $40 million in venture capital funding, Air Company has received numerous accolades, including TIME Best Inventions and the Keeling Curve Prize, highlighting its innovative approach to carbon technologies. Through its initiatives, Air Company aims to contribute significantly to reducing greenhouse gas emissions and promoting a regenerative future aligned with nature.

Oxylus Energy

Seed Round in 2024
Oxylus Energy focuses on innovative carbon utilization technology aimed at producing sustainable e-fuels from captured carbon dioxide. By employing a proprietary electrochemical process, the company converts CO2 into methanol, a clean-burning and versatile fuel. This approach not only provides a valuable waste product transformation but also supports the industrial sector in reducing dependence on fossil fuels, contributing to significant carbon reductions. Oxylus Energy is committed to making carbon capture and conversion competitive, scalable, and sustainable, ultimately promoting a decarbonized future.

Halda Therapeutics

Series B in 2024
Halda Therapeutics is a research-stage drug discovery company focused on developing next-generation precision medicines. The company utilizes a novel therapeutic modality aimed at creating treatments that can address various disease states. By modifying disease-causing pathways, Halda Therapeutics seeks to enable healthcare providers to offer tailored therapies to patients, enhancing the effectiveness of treatment based on individual patient needs.

Aware Recovery Care

Venture Round in 2024
Aware Recovery Care is a healthcare company that specializes in in-home addiction treatment services, employing a unique model designed to assist individuals, particularly young adults, struggling with substance use disorders. The company provides a comprehensive range of home-based care options, including in-home withdrawal management, medication-assisted treatment, individual and family therapy, and integrated medical and behavioral healthcare. This innovative approach allows patients to seek recovery in a familiar environment, enhancing their overall health and wellness. By transforming the home into a supportive treatment center, Aware Recovery Care delivers collaborative care that incorporates lived experiences, ensuring that individuals receive effective and personalized support on their journey to recovery.

Encapsulate

Seed Round in 2024
Encapsulate specializes in automated tumor-on-a-chip technology, which allows for the growth and preservation of cancer cells outside the body. This innovative approach enables the creation of micro tumors from patients' cancer cells, facilitating the assessment of how these cells respond to various chemotherapy and biotherapy drugs. By evaluating the efficacy of treatments on an individualized basis, Encapsulate's technology aids oncologists in determining effective personalized treatment regimens for cancer patients, starting from the initial diagnosis. This method enhances the ability to tailor cancer therapies to the specific needs of each patient, thereby improving treatment outcomes.

Quantum Circuits

Venture Round in 2024
Quantum Circuits, Inc. specializes in the development and manufacture of quantum computers utilizing superconducting devices. Founded in 2015 and located in New Haven, Connecticut, the company aims to innovate in the field of quantum computing by delivering full-stack systems that efficiently scale. Led by Dr. Robert Schoelkopf, a prominent figure in quantum science, Quantum Circuits employs a unique dual-rail quantum qubit design that incorporates built-in hardware error detection and conversion. This approach allows for a highly scalable error-corrected system, requiring significantly fewer physical qubits per logical qubit and providing a more efficient pathway to fault-tolerant quantum computing. By focusing on solid-state quantum bits, the company enables clients to perform error-free computations, thereby accelerating research and advancing the practical applications of quantum technology.

Manifest Technologies

Seed Round in 2024
Manifest Technologies advances AI-powered computational neuroimaging system that quantifies neural and symptom data.

Conduce Health

Seed Round in 2024
Conduce Health is a healthcare technology company focused on providing a comprehensive solution for multi-specialty value-based care. The company operates a platform designed to connect risk-bearing entities with specialists, addressing the challenges associated with specialty care risks. By offering downside protection on these risks, Conduce Health streamlines the contracting process for participation in value-based care, increases patient volume, and facilitates the matching of patients with optimal specialists. This approach aims to promote healthier lives through personalized care and proactive management of well-being, ultimately enhancing the efficiency and effectiveness of healthcare delivery.

DeepLook Medical

Seed Round in 2024
DeepLook Medical is a medical software. They use shape-recognition software to extract and assemble that data, revealing radiomic features that uniquely reflect tissue morphology. The phenotype database for mammography is a database of breast cancer morphology offered today for research purposes only.

Nest Collaborative

Series A in 2024
Nest Collaborative operates a virtual lactation support platform that connects parents and parents-to-be with board-certified lactation consultants. Accessible year-round, the service focuses on preventive care to enhance breastfeeding success by addressing the unique barriers mothers face, including physiological, emotional, and societal challenges. Through education, guidance, and practical support, Nest Collaborative aims to extend the duration of breastfeeding. The platform provides a comprehensive range of services, including prenatal planning and ongoing support, allowing mothers to easily schedule consultations online without the need for co-pays. By combining evidence-based interventions with accessible care, Nest Collaborative seeks to improve overall maternal and infant health outcomes.

Vytyl Health Management

Series A in 2024
Vytyl Health Management delivers quality mental health care to adolescents and transitional-age youth. The organization firmly believes that connection forms the basis for healing. They recognize the significant challenges ahead but remain steadfast in their conviction that through collaborative efforts, barriers can be overcome, meaningful bonds can be formed, and vital assistance can be extended to those in greatest need.

IntelliBoard

Venture Round in 2023
IntelliBoard, Inc. is a developer of a learning analytics platform focused on delivering insights and reporting services to educational institutions and corporate clients. Founded in 2015 and based in Monroe, Connecticut, IntelliBoard's platform integrates with various Learning Management Systems (LMS) to provide comprehensive data analysis tools. These tools enable faculty and management to access real-time data on learner engagement, performance, and the effectiveness of educational content. By presenting statistical data in an accessible format, including charts and formatted reports, IntelliBoard helps institutions make informed decisions, improve learning outcomes, and enhance operational efficiency. The company's mission is to empower clients to achieve their educational goals and maximize the return on their e-learning investments.

Cambium Carbon

Seed Round in 2023
Cambium Carbon is an early-stage social enterprise focused on addressing climate change through reforestation and urban wood reuse. The company collaborates with cities and various partners to divert fallen city trees from landfills, transforming them into valuable resources. By establishing reforestation hubs, Cambium Carbon creates a circular economy that reclaims urban wood waste and generates revenue. This revenue is then invested in planting and maintaining trees, supporting city planners in creating sustainable jobs and fostering resilient urban environments. Through these initiatives, Cambium Carbon aims to implement effective natural climate solutions while promoting local regenerative wood supply chains.

Summer

Series A in 2023
Summer offers comprehensive property management services focused on vacation homes. The company operates a homeownership platform designed to assist clients in purchasing second homes and renting them out. By combining a rent-to-own program with short-term rental options, Summer aims to lower both the initial investment and ongoing costs associated with owning a second home. This approach simplifies the process, minimizing bureaucratic hurdles and allowing users to either move into ready-to-live-in homes or select their preferred second home.

Slooh

Venture Round in 2023
Slooh, LLC, founded in 2003 and based in Washington Depot, Connecticut, offers an innovative platform for public engagement in astronomy by providing online access to robotic telescopes located in various observatories worldwide. The company connects these telescopes to the internet, allowing users to view celestial events in real-time and participate in astronomical discoveries. Slooh has developed partnerships with institutions such as NASA and the Institute of Astrophysics of the Canary Islands, enhancing its credibility in the field. Through its automated observatories, Slooh has facilitated the capture of millions of celestial images and has broadcast live events like eclipses and asteroid observations, featuring expert narration. The platform is geared towards making astronomy accessible and affordable, particularly for educational institutions, enabling students and the public to explore the universe collaboratively with guidance from astronomy educators.

Anonybit

Seed Round in 2023
Anonybit develops a decentralized framework aimed at enhancing compliance, protecting identity, and securing personal assets. The company specializes in encrypting sensitive information such as biometrics and private keys, distributing this data across a peer-to-peer network of nodes. Anonybit employs patented technologies, including multi-party computing and zero-knowledge proofs, to facilitate secure matching functions in a decentralized environment. Its flagship product, the Genie, serves as an integrated identity management platform designed with privacy in mind. This platform streamlines the entire lifecycle of digital identity, from onboarding to authentication, effectively closing vulnerabilities that could be exploited by attackers and allowing users to safeguard their online identities.

Modifi Bio

Seed Round in 2023
Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drug development methods.

Raise Green

Seed Round in 2023
Raise Green is a financial technology company focused on promoting a sustainable future through equity crowdfunding. The company provides a platform that enables everyday individuals to invest in clean energy and climate solution projects, thereby democratizing access to renewable energy ownership. By facilitating community-driven project finance, Raise Green empowers community leaders to develop their own clean energy initiatives, such as community solar projects, allowing them to benefit from shared ownership. This approach not only helps combat climate change but also addresses income inequality by creating investment opportunities that are accessible to a wider audience. Through its efforts, Raise Green aims to enhance community resilience and support the transition to a decarbonized economy.

Oova

Series A in 2023
Oova Inc. is a fertility diagnostic company based in New York that specializes in developing personalized fertility testing solutions. Founded in 2017, Oova spun out from Mount Sinai Hospital and utilizes patent-pending biochemistry and artificial intelligence to analyze hormonal levels in women's urine. The company's innovative paper-based testing strips measure key hormones, such as luteinizing hormone and progesterone, allowing women to manage their menstrual cycles, assess fertility, and monitor reproductive health conditions like polycystic ovary syndrome (PCOS). By facilitating daily urine sample collection and offering real-time insights through a mobile application, Oova supports women in achieving their conception goals while seamlessly integrating into their daily lives.

Driver Technologies

Venture Round in 2023
Driver Technologies Inc. is a New York-based company that specializes in mobile application software focused on enhancing road safety. Founded in 2017, the company offers a hardware-free app that allows users to video record their trips while providing real-time alerts about potential hazards, such as the risk of colliding with other vehicles or pedestrians, lane drifting, and drowsiness. The app incorporates voice control features, facilitating safe access to entertainment, news, and navigation services without requiring physical interaction. Additionally, Driver Technologies aims to help users document their driving experiences, which can be useful for insurance purposes and improving overall safety on the road.

2045 Studio

Pre Seed Round in 2023
2045 Studio is a members-only network aimed at influential professionals of color, which collaborates with corporations to foster employee belonging, retention, and promotion. The organization develops a community platform that assists users in identifying new members within their companies, supporting both corporate and individual needs. Its B2B offerings focus on helping organizations cultivate inclusive leadership, while the B2C segment allows individuals to join curated networks centered around industry-specific groups. By creating spaces for individuals with shared lived experiences, 2045 Studio facilitates personal and professional growth, enabling meaningful connections among its members.

Inbox Health

Series B in 2023
Inbox Health Corp. is a digital healthcare company that focuses on improving patient communication regarding medical billing in the United States. Established in 2014 and based in New Haven, Connecticut, the company offers a platform that automates the patient communication process through bi-directional correspondence and advanced technologies such as machine learning and artificial intelligence. This platform helps patients better understand their medical bills and provides various payment options. By analyzing data from its customer base, Inbox Health enables medical billers to customize the billing and communication experience for each patient, thereby enhancing collections and overall patient satisfaction. The company's mission is to reduce administrative inefficiencies in healthcare by streamlining the billing and payment processes for patients.

RNAConnect

Seed Round in 2023
RNAConnect provides enzymatic tools for visualizing and manipulating RNA.

Bright Feeds

Seed Round in 2023
Bright Feeds is a company focused on food waste recycling, utilizing artificial intelligence and drying technology to convert food waste into animal feed. The company addresses pressing issues such as climate change and global food insecurity by offering a service that diverts unwanted food from landfills. By transforming this waste into a nutrient-rich alternative to traditional feed sources like soy and corn, Bright Feeds helps businesses achieve their sustainability objectives while enhancing profit margins. This innovative approach not only reduces food waste but also provides a valuable resource for the animal agriculture industry.

ReferWell

Series B in 2023
ReferWell operates a cloud-based platform that addresses the challenges associated with care transitions in healthcare. By connecting providers into Virtually Integrated Networks, ReferWell enhances visibility and coordination throughout the patient journey, ensuring efficient communication among providers and payers. The platform enables healthcare organizations to guide patients toward high-quality providers, thereby improving patient compliance, reducing leakage, and closing care gaps. Additionally, ReferWell's comprehensive services streamline referrals, facilitate point-of-care appointment scheduling, and support care teams with features such as provider directory management, eConsult, and telehealth capabilities. This holistic approach not only enhances patient experiences and outcomes but also aids clients in increasing revenue and improving healthcare metrics.

Bags

Seed Round in 2022
Bags is a loan discovery and management platform, built by and for the culture.

CINCH Holdings

Pre Seed Round in 2022
CINCH has created the first end-to-end real estate transaction ecosystem, providing agents and brokers everything they need to get deals done within a single application.

Peer Robotics

Seed Round in 2022
Peer Robotics is a company focused on developing collaborative mobile robotics aimed at enhancing material handling for small and medium-sized manufacturers. The company's robots are designed to work alongside humans, adapting to their actions in real-time to improve efficiency. These versatile mobile robots facilitate various tasks, including material movement, packaging, sorting, and visual inspection within warehousing, manufacturing, and assembly environments. By bridging the gap between human and robotic collaboration, Peer Robotics enables operators to optimize workflows and ensure timely delivery of goods, ultimately improving operational efficiency.

Aceiss

Seed Round in 2022
Aceiss is a developer of a compliance monitoring platform that enhances access security by providing visibility and insights into user access. The company's technology seamlessly integrates with existing applications and security infrastructure, allowing organizations to identify anomalous behavior and monitor privileged accounts. This capability enables businesses to anticipate potential security threats and take proactive measures to protect their sensitive information. By delivering immediate insights upon integration, Aceiss helps organizations strengthen their security posture and ensure compliance with regulatory requirements.

Modifi Bio

Seed Round in 2022
Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drug development methods.

Noteworthy AI

Seed Round in 2022
Noteworthy AI specializes in enhancing the management and evaluation of electric distribution grids through advanced technology. The company provides fleet-mounted smart cameras that capture critical data during routine vehicle operations. This data is processed by an artificial intelligence platform that monitors equipment conditions, identifies defects, and supports utilities in improving the reliability, safety, and efficiency of their operations. Noteworthy's solutions also facilitate various applications, including asset inspection, vegetation management, joint use compliance, and lighting audits, while effectively lowering operational and maintenance costs for electric utility companies.

FinTron

Series A in 2022
FinTron is a fintech company that offers investment and banking solutions tailored for the mobile generation, particularly targeting young post-college graduates. The platform provides users with curated investment portfolios and educational resources, helping them build a strong foundation for investing. Additionally, FinTron features a business-to-business embedded wealth technology system that enhances financial freedom by consolidating essential financial data. Users can track their debt, savings, and investment accounts through a single application, allowing for streamlined access to vital information and updates regarding their financial and investment activities.

Torigen Pharmaceuticals

Venture Round in 2022
Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.

Plazmod

Pre Seed Round in 2022
Plazmod specializes in developing a technology for processing structured materials, aimed at supporting the transition of the global energy system towards electrification. The company has created an innovative battery manufacturing process that commercializes this advanced materials processing technology. By enabling industries to adopt electrification more effectively, Plazmod plays a significant role in transforming energy systems worldwide.

Upswing Health

Seed Round in 2022
Upswing Health is a digital sports medicine platform that aims to revolutionize orthopedic care for athletes. By utilizing artificial intelligence and medical expertise, Upswing Health offers a community-powered solution that helps athletes identify and manage injuries related to various body parts, including the ankle, knee, elbow, and shoulder. The platform is designed to address low- and medium-acuity orthopedic issues, coordinating care between Athletic Trainers and Orthopedic Specialists. This innovative care delivery model not only reduces costs but also enhances patient outcomes across the musculoskeletal care continuum, ensuring that athletes receive convenient access to quality information and guidance on their recovery journey.

Encapsulate

Convertible Note in 2022
Encapsulate specializes in automated tumor-on-a-chip technology, which allows for the growth and preservation of cancer cells outside the body. This innovative approach enables the creation of micro tumors from patients' cancer cells, facilitating the assessment of how these cells respond to various chemotherapy and biotherapy drugs. By evaluating the efficacy of treatments on an individualized basis, Encapsulate's technology aids oncologists in determining effective personalized treatment regimens for cancer patients, starting from the initial diagnosis. This method enhances the ability to tailor cancer therapies to the specific needs of each patient, thereby improving treatment outcomes.

CoreChain Technologies

Seed Round in 2022
CoreChain Technologies operates a business-to-business payments network that utilizes blockchain technology to enhance the efficiency and security of transactions. The company's platform is designed to facilitate the exchange of funds and transaction data between businesses, thereby reducing the manual processes that can lead to errors and reconciliation issues. By automating these exchanges within a secure environment, CoreChain Technologies aims to help businesses streamline their B2B payments and unlock working capital that may be tied up in traditional payment processes.

Source Defense

Series B in 2022
Source Defense Ltd. specializes in website security software aimed at preventing attacks originating from third-party sources. Established in 2014 and headquartered in Rosh-ha’ayin, Israel, with additional offices in Beer-Sheva and Stamford, Connecticut, the company offers a real-time Software-as-a-Service platform. This platform empowers site owners to set and enforce permissions, receive real-time alerts, and monitor the behavior of third-party vendors on their sites. Source Defense provides tailored solutions for various sectors, including financial institutions, insurance companies, e-commerce, and content publishers. By focusing on prevention rather than detection, Source Defense helps organizations eliminate security concerns associated with third-party integrations, ultimately allowing them to concentrate on enhancing revenue opportunities while ensuring the safety and performance of their websites.
Covr Financial Technologies, Inc. operates as a digital brokerage general agency, providing life, long-term care, and disability insurance solutions tailored for financial institutions, their advisors, and clients. The company's offerings include the Covr Advisor platform, which enables financial advisors to efficiently meet their clients' insurance needs by selecting appropriate products, and the Covr Consumer platform that allows banks and credit unions to sell insurance directly to customers online. Additionally, Covr Insights assists in managing and analyzing existing life insurance policies. Founded in 2013 and based in Boise, Idaho, Covr serves over 24,000 financial advisors and 13 million customers across various financial institutions, including wealth management firms, banks, and credit unions. The company is supported by notable venture capital investors and features an advisory board that includes prominent figures from the financial services industry.

1906

Venture Round in 2022
1906 is a cannabis company founded in 2016 that focuses on creating fast-acting, functional products aimed at enhancing wellness. Named after the year cannabis was last widely used as medicine, 1906 aims to reintegrate the plant into society as a health tool rather than simply for recreation. The company differentiates itself in the cannabis market by offering premium products that address specific wellness needs such as sleep, focus, relaxation, energy, and intimacy. Unlike many brands that prioritize high THC content, 1906 targets health-conscious consumers seeking predictable effects. Its proprietary fast-acting technology allows products to take effect within 20 minutes, significantly quicker than typical edibles. This emphasis on consistent dosing and rapid onset makes 1906 appealing to a diverse customer base, including professionals and health enthusiasts. With a direct-to-consumer platform launched in 2023, the company is expanding its reach across legalized states. As consumer demand for wellness-oriented cannabis products grows, 1906 is well-positioned for sustained success in the evolving cannabis landscape.

Nest Collaborative

Seed Round in 2022
Nest Collaborative operates a virtual lactation support platform that connects parents and parents-to-be with board-certified lactation consultants. Accessible year-round, the service focuses on preventive care to enhance breastfeeding success by addressing the unique barriers mothers face, including physiological, emotional, and societal challenges. Through education, guidance, and practical support, Nest Collaborative aims to extend the duration of breastfeeding. The platform provides a comprehensive range of services, including prenatal planning and ongoing support, allowing mothers to easily schedule consultations online without the need for co-pays. By combining evidence-based interventions with accessible care, Nest Collaborative seeks to improve overall maternal and infant health outcomes.

NourishedRx

Seed Round in 2022
NourishedRx is a provider of personalized food solutions aimed at health plan members and patients with diet-sensitive chronic health conditions, particularly those experiencing nutrition insecurity. Founded in 2019 in Stamford, Connecticut, the company delivers customized meal plans and meal prep kits tailored to individual eating habits. In addition to food solutions, NourishedRx offers educational resources and support to promote lasting behavior change, ultimately enhancing member engagement and satisfaction. The company's approach is designed to improve clinical outcomes and deliver significant cost savings for both individuals and healthcare systems.

Wellinks

Series C in 2021
Wellinks, Inc., based in New Haven, Connecticut, specializes in wearable health technology aimed at improving clinical outcomes. Initially founded as 109 Design LLC in 2014, the company develops innovative devices for managing conditions such as scoliosis and chronic obstructive pulmonary disease (COPD). Wellinks offers a smart strap that enables patients, parents, and healthcare providers to monitor the duration and fit of scoliosis braces, thereby preventing the need for surgeries. The technology provides real-time data and feedback, empowering users to make informed decisions about their treatment. Additionally, Wellinks focuses on individualized care for COPD patients, offering digital health systems that support remote monitoring and management of respiratory conditions, enhancing patient engagement and health outcomes. The company operates as a subsidiary of Convexity Scientific Inc.

VeraDermics

Series A in 2021
VeraDermics is a dermatology company focused on developing innovative solutions for skin conditions, particularly warts. The company has created a dissolvable microneedle patch that delivers immunotherapy painlessly, stimulating the body's immune response to combat the wart virus. This patch is designed to be applied like a bandage and remains on the skin for less than an hour. During this time, the microneedles, made from immune stimulators embedded in a polymer matrix, dissolve and are implanted into the skin. After the adhesive backing is removed, the microneedles continue to dissolve over the following weeks, releasing immune stimulators directly into the wart. This method not only provides a pain-free treatment option but also simplifies the administration process for medical practitioners and enhances patient comfort.

futuresTHRIVE

Seed Round in 2021
FuturesTHRIVE specializes in an AI-driven platform aimed at enhancing pediatric mental health care. The company's technology leverages artificial intelligence, sentiment analysis, and machine learning to establish a mental health baseline, enabling healthcare providers and families to gain insights into a child's mental health characteristics. This innovative approach facilitates the early identification of mental health conditions and risk factors among children, thereby supporting timely interventions. By focusing on the unique mental health needs of youth, FuturesTHRIVE addresses the growing concerns surrounding children's mental well-being and promotes proactive monitoring and support.

Lessonbee

Seed Round in 2021
Lessonbee Inc. is an online learning platform focused on health and wellness education for students in grades K-12. Founded in 2017 and headquartered in Mount Vernon, New York, the company provides a cloud-based reflective learning system that includes adaptive lessons and a shared content library. This platform allows educators to access current and relevant educational content, manage student assignments, and foster engagement through regular reflection. Lessonbee emphasizes culturally responsive and medically accurate health education, equipping students with the knowledge and skills to promote healthy living. Additionally, it utilizes proprietary analytics to assess student health goals and school climate, recommending tailored content from a diverse library of self-paced classes, adaptive courses, and video-based lessons that align with state and national health education standards. The platform aims to enhance personalized health education and support social-emotional learning for students both at home and in school.

Owl's Brew

Series A in 2021
Brew Lab Tea creates all-natural loose leaf tea blends, carefully crafted in NYC. Founded in 2013, by tea sommelier Jennie Ripps and Maria Littlefield, Owl's Brew sells two product lines. Owl's Brew Mixer, tea-based craft cocktail mixers, and Owl's Brew Boozy Tea.

DiA Imaging Analysis

Venture Round in 2021
DiA Imaging Analysis Ltd. specializes in AI-driven ultrasound analysis technology aimed at enhancing cardiac function diagnostics. Established in 2009 and based in Beersheba, Israel, the company provides a suite of automated tools, including LVivo EF for ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain for assessing myocardial strain. These solutions address common challenges faced by clinicians, such as obtaining optimal images and accurately analyzing them for clinical abnormalities. DiA's products, which can be integrated into any ultrasound device or healthcare IT system, also include LVivo SAX for detecting coronary heart disease and LVivo Mobile for mobile ultrasound analysis. The company holds regulatory clearances for its cardiac toolbox and serves a global user base, reflecting its commitment to making ultrasound analysis smarter and more accessible.

Shelf

Series B in 2021
Shelf is a highly awarded Knowledge Automation platform designed to help remote workers instantly find the answers they need. Its MerlinAI technology delivers answers directly through the tools the team uses daily. Built on a modern tech stack, Their solution meets stringent security standards. In all the ways traditional knowledge bases fail, Shelf succeeds.

CoreChain Technologies

Pre Seed Round in 2021
CoreChain Technologies operates a business-to-business payments network that utilizes blockchain technology to enhance the efficiency and security of transactions. The company's platform is designed to facilitate the exchange of funds and transaction data between businesses, thereby reducing the manual processes that can lead to errors and reconciliation issues. By automating these exchanges within a secure environment, CoreChain Technologies aims to help businesses streamline their B2B payments and unlock working capital that may be tied up in traditional payment processes.

BEKHealth

Seed Round in 2021
BEKhealth specializes in clinical research software that enhances the efficiency of clinical trials and observational studies. The company utilizes an AI-powered platform for chart abstraction and patient matching, which enables organizations to gain deeper insights into their patient populations. By extracting structured and unstructured data from electronic medical records, BEKhealth's technology captures three times more trial criteria, thereby facilitating faster feasibility assessments, optimizing site selection, and identifying clinically qualified participants more effectively. This approach not only accelerates timelines but also aims to increase the number of protocol-eligible candidates significantly, leading to enhanced enrollment processes and reduced costs for clients.

Triax Technologies

Series A in 2021
Triax Technologies offers a connected Internet of Things (IoT) worksite platform tailored for construction, energy, and heavy industrial sectors. The company focuses on enhancing safety, efficiency, and visibility in challenging work environments through innovative technology and real-time data analytics. Its flagship product, the Spot-r system, connects workers, equipment, and operations using a minimal infrastructure network, wearable devices, and a cloud-based dashboard. This system provides real-time insights into site access, worker and equipment locations, safety incidents, and emergency procedures, enabling firms to make informed decisions and streamline operations. In response to the COVID-19 pandemic, Triax launched Proximity Trace, an IoT solution designed to assist in workplace safety by offering proximity distancing alerts and contact tracing. This initiative aims to protect essential workers while facilitating their safe return to work in compliance with social distancing guidelines. Overall, Triax Technologies is committed to transforming worksite management through intelligent technology and actionable insights.

Lumeda

Series A in 2021
Lumeda Inc. is a biotechnology company focused on developing advanced photonic tools for intraoperative photodynamic therapy (PDT) to treat lung cancer. Founded in 2020 and based in Rocky Hill, Connecticut, the company aims to enhance the efficacy and ease of PDT procedures. Lumeda's innovative solutions include light delivery instrumentation and proprietary software that automates the delivery of light to targeted tumors with precise dosimetry profiles. By integrating advanced photonics with artificial intelligence, Lumeda's technology improves treatment planning and performance, allowing for a streamlined and reliable intraoperative PDT procedure. This approach not only addresses tumor margins during conventional non-small cell lung cancer resections but also seeks to reduce post-operative recurrence and improve overall patient outcomes.

Inbox Health

Series A in 2021
Inbox Health Corp. is a digital healthcare company that focuses on improving patient communication regarding medical billing in the United States. Established in 2014 and based in New Haven, Connecticut, the company offers a platform that automates the patient communication process through bi-directional correspondence and advanced technologies such as machine learning and artificial intelligence. This platform helps patients better understand their medical bills and provides various payment options. By analyzing data from its customer base, Inbox Health enables medical billers to customize the billing and communication experience for each patient, thereby enhancing collections and overall patient satisfaction. The company's mission is to reduce administrative inefficiencies in healthcare by streamlining the billing and payment processes for patients.

Enko Chem, Inc.

Venture Round in 2021
Enko Chem, Inc. is a biotechnology company based in Woburn, Massachusetts, that focuses on discovering and developing innovative small-molecule products designed to protect crops from pests and diseases. Founded in 2017, the company utilizes a proprietary technology platform that enables the rapid identification of safe and cost-effective solutions aimed at promoting sustainable food production. Through its efforts, Enko Chem seeks to address the challenges faced by farmers in maintaining crop health while ensuring environmental sustainability.

Artizan Biosciences

Series A in 2021
Artizan Biosciences, Inc. is a biotechnology company based in New Haven, Connecticut, founded in 2016. The company focuses on developing small molecule drugs aimed at treating serious diseases linked to intestinal inflammation. Utilizing its proprietary IgA-SEQ technology platform, Artizan distinguishes disease-driving bacteria within the intestinal microbiota. This innovative approach enables the development of precision therapeutics designed to address unmet medical needs in various conditions, including digestive disorders, obesity, autoimmune diseases, and disorders affecting the skin, lungs, and central nervous system. Through its research, Artizan aims to provide new and potentially curative treatment options for patients suffering from these diverse health challenges.

Leal Health

Series A in 2021
Leal Health, formerly known as Trialjectory, is an AI-powered platform focused on enhancing cancer care by facilitating connections between patients and suitable clinical trials. The company collaborates with patients, healthcare providers, and pharmaceutical firms to make advanced cancer treatments more accessible and to support patient-centric clinical trials. Utilizing self-reported clinical data, Leal's platform streamlines the search and enrollment process for cancer patients and their physicians, ensuring they can find appropriate treatment options effectively. Leal Health has gained recognition for its innovative approach, being named one of TIME's "The 100 Best Inventions of 2020" and receiving an honor in the AI and data category at Fast Company's "2021 World-Changing Ideas Awards."

Athena Therapeutics

Seed Round in 2020
Athena Therapeutics developed cutting-edge approaches to probe for, identify, and characterize altered states of NAD metabolism and flux. The Company has recruited a team of researchers with critical expertise in NAD metabolism including Dr. Emmanuel Burgos, formerly of the Albert Einstein College of Medicine, to lead the internal discovery biology capabilities and establish a suite of NAD pathway targets for development. To complement internal expertise, Athena has assembled a Scientific Advisory Board of world experts, which includes Professor Vern Schramm of the Albert Einstein College of Medicine, a world-renown enzymologist specializing in NAMPT and drug design, and Dr. Leonard Post, a seasoned oncology drug developer and discoverer of the PARP inhibitor talazoparib.

Diameter Health

Series B in 2020
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.

Alphina Therapeutics

Venture Round in 2020
Alphina Therapeutics is a biotechnology company focused on developing innovative therapies for cancer patients by targeting NAD Metabolic Deficiencies (NMD). The company utilizes proprietary biomarkers and insights to create companion diagnostics that identify specific cancer patient subsets with NMD. By targeting multiple nodes in NAD synthesis pathways, Alphina aims to develop selective small molecules that can effectively treat tumors while minimizing impact on normal tissues. Their approach involves characterizing altered states of NAD metabolism, enabling the development of new drug classes tailored to address defects in NAD metabolism associated with cancer. The ultimate goal is to translate these advancements quickly into clinical applications for improved cancer treatment.

WRM Software

Seed Round in 2020
WRM Software develops business productivity applications focused on improving business processes. WRM's storm manager and ops manager applications are designed to be easy-to-use and connect field and office operations seamlessly. It ensures everyone to have access to the latest information at all times.

Azitra

Series B in 2020
Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

Point Pickup

Series A in 2020
Point Pickup Technologies is a mobile app-based delivery platform that addresses on-demand, pre-scheduled, and recurring same-day delivery needs across various industries. The platform caters to a wide range of sectors, including retail, grocery, liquor, specialty foods, automotive, pharmaceuticals, and manufacturing. Utilizing precision matching technology, Point Pickup connects delivery requests from individuals and businesses with the most suitable drivers, taking into account factors such as vehicle type, location, and route. This approach allows organizations to efficiently deliver goods on the same day while providing real-time tracking of packages. The company operates in major markets throughout the United States and focuses on underserved secondary markets, leveraging a diverse network of independent drivers, which includes both everyday individuals with cars and professional commercial vehicle operators.

BioRez

Seed Round in 2020
Biorez, Inc. is a medical device company specializing in the development of bioresorbable scaffold implants aimed at regenerating functional tissue in vivo. Founded in 2008 and based in New Haven, Connecticut, Biorez offers innovative products such as an off-the-shelf implant for anterior cruciate ligament (ACL) reconstruction, which eliminates the need for harvesting donor tissue and serves as a superior alternative to cadaver-based materials. The company's technology utilizes a degradable polymer, specifically PLLA, to create implants that stabilize surgical repairs and facilitate the body's natural tissue regeneration, thereby enhancing musculoskeletal outcomes. Among its product lineup is the L-C Ligament® and the biorez GRAFT™, an FDA-cleared device designed for soft tissue augmentation of the rotator cuff. By leveraging this technology, Biorez aims to accelerate patient recovery and improve surgical outcomes in orthopedic procedures.

IvyTech Design

Seed Round in 2020
IvyTech Design was founded with a mission to develop adjustable-angle orthopedic instruments that can distract, align, and compress bones more precisely than current tools. Our patented and patent-pending technology addresses key challenges in foot and spine procedures, which suffer from high complication rates (up to 20-25%), costly revision surgeries, and suboptimal patient outcomes. IvyTech Design’s instruments will enable surgeons to precisely angle bones, providing superior alignment and access in foot and spine operations. Surgeons, hospitals, and patients will all benefit from this technology, as we aim to lower complication and revision rates, reduce surgical times, and improve patient outcomes.

Shelf

Series A in 2020
Shelf is a highly awarded Knowledge Automation platform designed to help remote workers instantly find the answers they need. Its MerlinAI technology delivers answers directly through the tools the team uses daily. Built on a modern tech stack, Their solution meets stringent security standards. In all the ways traditional knowledge bases fail, Shelf succeeds.

Encapsulate

Pre Seed Round in 2020
Encapsulate specializes in automated tumor-on-a-chip technology, which allows for the growth and preservation of cancer cells outside the body. This innovative approach enables the creation of micro tumors from patients' cancer cells, facilitating the assessment of how these cells respond to various chemotherapy and biotherapy drugs. By evaluating the efficacy of treatments on an individualized basis, Encapsulate's technology aids oncologists in determining effective personalized treatment regimens for cancer patients, starting from the initial diagnosis. This method enhances the ability to tailor cancer therapies to the specific needs of each patient, thereby improving treatment outcomes.

EyeControl

Series A in 2020
EyeControl is a pioneer in medical technology focused on innovative communication solutions for healthcare. The company has developed a unique device aimed at improving the quality of life for patients with locked-in syndrome, particularly those suffering from ALS. This device consists of a simple glass frame equipped with an infrared camera that connects to a compact computer. It translates the patients' blinks and eye movements into commands, which are then converted into speech through earphones and a speaker. By leveraging advanced technology, EyeControl addresses significant communication barriers, enabling patients to express their needs and preferences more effectively.

Voiceitt

Series A in 2020
Voiceitt is an automatic speech recognition technology platform. Voiceitt provides a new dimension of independence and quality of life for people with speech and motor disabilities, and a useful tool for those who care for and about them.

GeneDx

Series C in 2020
GeneDx is dedicated to providing personalized health insights that enhance diagnosis, treatment, and drug discovery. By integrating extensive genomic expertise with advanced data interpretation capabilities, the company aims to establish precision medicine as a standard in healthcare. GeneDx specializes in exome and genome testing and interpretation, leveraging one of the largest rare disease data sets available. Its operations are divided into two segments: GeneDx, which generates the majority of revenue, and Legacy Sema4 diagnostics. Through these efforts, GeneDx is positioned to significantly impact health outcomes by using genomic and large-scale clinical information.

Enrich Therapeutics

Seed Round in 2020
Enrich Therapeutics is a biotechnology startup focused on the development of novel single-cell isolation platform along with the critical life science applications.

Simcha Therapeutics

Series A in 2020
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer. The company uses directed evolution to engineer novel cytokines designed to unlock the precision and power of the immune system. Simcha’s lead program, ST-067, is a designer IL-18 cytokine that has shown potent antitumor effects in animal models, both as a monotherapy and when combined with anti-PD-1 checkpoint inhibitors, as described in Nature in June 2020. It was founded in 2018 and is headquartered in New Haven, Connecticut, USA.

Invixium

Series C in 2020
Invixium Inc. is a Canadian company specializing in biometric solutions aimed at enhancing access control, workforce management, and visitor screening for various industries. Established in 2012 and headquartered in Markham, Canada, Invixium designs a range of innovative products, including the Ixm Mycro, Ixm Touch, IXM Titan, IXM Merge, and Ixm Sense, which cater to both residential and industrial environments. These products incorporate advanced technologies such as face recognition, fingerprint tracking, and temperature detection to ensure security and health in workplaces. Invixium's fully integrated hardware and software solutions provide valuable analytics that improve safety and productivity. With a management team boasting over 200 years of collective experience in the biometric access control sector, Invixium's products have been deployed in diverse sectors, including government, healthcare, and education, across more than 60 countries. The company's commitment to quality is reflected in its manufacturing process, with all products proudly made in Canada.

1touch.io

Series A in 2020
By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you, 1touch.io can track it for you.

Covr Financial Technologies

Convertible Note in 2020
Covr Financial Technologies, Inc. operates as a digital brokerage general agency, providing life, long-term care, and disability insurance solutions tailored for financial institutions, their advisors, and clients. The company's offerings include the Covr Advisor platform, which enables financial advisors to efficiently meet their clients' insurance needs by selecting appropriate products, and the Covr Consumer platform that allows banks and credit unions to sell insurance directly to customers online. Additionally, Covr Insights assists in managing and analyzing existing life insurance policies. Founded in 2013 and based in Boise, Idaho, Covr serves over 24,000 financial advisors and 13 million customers across various financial institutions, including wealth management firms, banks, and credit unions. The company is supported by notable venture capital investors and features an advisory board that includes prominent figures from the financial services industry.

IntelliBoard

Series A in 2020
IntelliBoard, Inc. is a developer of a learning analytics platform focused on delivering insights and reporting services to educational institutions and corporate clients. Founded in 2015 and based in Monroe, Connecticut, IntelliBoard's platform integrates with various Learning Management Systems (LMS) to provide comprehensive data analysis tools. These tools enable faculty and management to access real-time data on learner engagement, performance, and the effectiveness of educational content. By presenting statistical data in an accessible format, including charts and formatted reports, IntelliBoard helps institutions make informed decisions, improve learning outcomes, and enhance operational efficiency. The company's mission is to empower clients to achieve their educational goals and maximize the return on their e-learning investments.

CytoVeris

Venture Round in 2020
CytoVeris is a company focused on developing optical-based technologies to assist surgical oncologists in identifying and removing tumor tissue during cancer resection surgeries. Founded in 2018 by Alan Kersey in Farmington, Connecticut, CytoVeris aims to enhance the surgeon's ability to achieve clean margins, thereby improving patient outcomes. The company’s devices facilitate real-time assessment of tissue and generate molecular-specific information by detecting unique signatures created by cancer cells that alter cellular metabolic processes. This includes variations in lipids, proteins, and metabolites, which can be identified using their OncoMap system. By providing oncologists with critical information during surgery, CytoVeris seeks to reduce healthcare costs associated with repeat surgeries.

Mindnest Health

Seed Round in 2020
MindNest Health, Inc. is a Connecticut-based company founded in 2016 that develops a digital platform for parent training, enabling caregivers to implement clinically validated behavioral interventions for children with conditions such as ADHD, autism, and disruptive behaviors. The platform aims to promote children's development by providing evidence-based solutions that address behavioral health challenges, including anxiety and depression. MindNest Health's approach seeks to eliminate barriers parents face when seeking help, thereby enhancing access to care for their children and reducing stress for families. Additionally, the company is focused on decreasing the overall cost of care for employers and payers, with a vision of fostering an environment where children and families can thrive.

WAVE Drowning Prevention Systems

Pre Seed Round in 2020
WAVE was created with a mission to end drowning, a leading cause of death in children and adults. Our product works with lifeguards and parents to detect drowning at the first sign of danger.

ReferWell

Venture Round in 2020
ReferWell operates a cloud-based platform that addresses the challenges associated with care transitions in healthcare. By connecting providers into Virtually Integrated Networks, ReferWell enhances visibility and coordination throughout the patient journey, ensuring efficient communication among providers and payers. The platform enables healthcare organizations to guide patients toward high-quality providers, thereby improving patient compliance, reducing leakage, and closing care gaps. Additionally, ReferWell's comprehensive services streamline referrals, facilitate point-of-care appointment scheduling, and support care teams with features such as provider directory management, eConsult, and telehealth capabilities. This holistic approach not only enhances patient experiences and outcomes but also aids clients in increasing revenue and improving healthcare metrics.

ProteoWise

Venture Round in 2020
ProteoWise’s technology provides a unique combination of high information content, high throughput, and low cost - all while simplifying the western blot dramatically. This combination is what’s driving the genomic revolution and is needed for proteomics. ProteoWise is founded by a seasoned team of scientists from the Strittmatter Lab at Yale University with a history of innovation.

Inbox Health

Venture Round in 2020
Inbox Health Corp. is a digital healthcare company that focuses on improving patient communication regarding medical billing in the United States. Established in 2014 and based in New Haven, Connecticut, the company offers a platform that automates the patient communication process through bi-directional correspondence and advanced technologies such as machine learning and artificial intelligence. This platform helps patients better understand their medical bills and provides various payment options. By analyzing data from its customer base, Inbox Health enables medical billers to customize the billing and communication experience for each patient, thereby enhancing collections and overall patient satisfaction. The company's mission is to reduce administrative inefficiencies in healthcare by streamlining the billing and payment processes for patients.

Aero Therapeutics

Pre Seed Round in 2020
Aero Therapeutics specializes in creating medical devices aimed at addressing respiratory issues, particularly in low-resource environments. The company's innovative device is designed specifically for neonatal care, offering a solution that oxygenates, warms, humidifies, and sterilizes air prior to delivery. This all-in-one mobile enclosure provides an affordable and effective option for clinicians treating infants with respiratory challenges in settings where resources may be limited. By focusing on accessibility and functionality, Aero Therapeutics aims to improve patient outcomes in vulnerable populations.

Lessonbee

Pre Seed Round in 2020
Lessonbee Inc. is an online learning platform focused on health and wellness education for students in grades K-12. Founded in 2017 and headquartered in Mount Vernon, New York, the company provides a cloud-based reflective learning system that includes adaptive lessons and a shared content library. This platform allows educators to access current and relevant educational content, manage student assignments, and foster engagement through regular reflection. Lessonbee emphasizes culturally responsive and medically accurate health education, equipping students with the knowledge and skills to promote healthy living. Additionally, it utilizes proprietary analytics to assess student health goals and school climate, recommending tailored content from a diverse library of self-paced classes, adaptive courses, and video-based lessons that align with state and national health education standards. The platform aims to enhance personalized health education and support social-emotional learning for students both at home and in school.

P2 Science

Series C in 2020
P2 Science a venture-backed, renewable specialty chemicals company, co-founded by Yale scientists, a chemical industry CEO and Elm Street Ventures, an early-stage venture fund. P2 Science has developed a unique process technology for converting renewable feedstocks—including vegetable oils—into high-value, specialty chemicals. These include flavor, fragrance and cosmetics ingredients. Many of their products are today available only from petrochemical sources. Among the first products to be produced by P2 are vegetable-derived, cost-effective versions of current petrochemical fragrance ingredients. Major users and formulators of specialty chemicals have a strong interest in substituting renewable for petrochemical ingredients. Patrick Foley, a Yale graduate of the PhD program in Environmental Engineering, is P2′s Chief Scientific Officer. Neil Burns, an executive with 20+ years experience in the specialty chemical industry, is the company’s CEO. P2 has a laboratory in New Haven, CT to support this technology’s development and commercialization, as well as partnerships with major companies at a number of points along the supply chain.

Enviro Power

Series A in 2020
Enviro Power, LLC, founded in 2013 and based in Hartford, Connecticut, specializes in the development and marketing of innovative heating equipment for both residential and commercial applications. The company offers two main products: the Commercial SmartWatt Boiler, designed for light-commercial and high-end residential settings, and the Residential SmartWatt Boiler for home use. Enviro Power's SmartWatt Boiler technology platform not only meets heating requirements but also generates electricity at nearly zero cost, providing backup power and enhancing grid stability. This system allows building owners to potentially reduce utility bills while simultaneously lowering their carbon footprint and contributing to improved grid resiliency.

IsoPlexis

Series C in 2020
IsoPlexis is a life science technology company based in Branford, Connecticut, founded in 2013. It focuses on developing a single-cell detection system that identifies patient immune responses at the single-cell level. This innovative platform enables the assessment of therapeutic safety and efficacy, as well as the monitoring of disease progression. IsoPlexis specializes in cell-based proteomic systems and biomarkers, providing insights into functional protein biology and cellular signaling networks with high resolution. By offering these capabilities, the company aids in predicting patient responses to novel immunotherapies and cellular therapies, ultimately enhancing therapeutic development and informing clinical decisions.

Better Rhodes

Seed Round in 2020
Better Rhodes is a premium beverage platform specializing in alcohol-free and low-alcohol beverages. The company focuses on delivering a curated selection of products, including alcohol-free spirits, beers, wines, mixers, and soft drinks, directly to customers' doorsteps through a subscription model. Better Rhodes also provides product development and wholesale services, making it a key player in the growing market for non-alcoholic alternatives.

BioWave

Venture Round in 2020
BioWave is a patented smarter pain blocking technology that delivers therapeutic electrical signals through skin into deep tissue right to the surface of pain fibers. The electrical field that forms around the pain fibers blocks the transmission of pain signals to the brain. The mechanism of action is similar to a chemical anesthetic like Novocain, except BioWave is blocking the transmission of the pain signal electrically instead of chemically. Because the pain signal is blocked at the nerve inside the body, a 30 minute treatment can provide up to 24 hours of continued pain relief. And there is a cumulative benefit with multiple treatments. BioWave manufactures and sells 3 medical device systems, BioWavePRO (Rx), BioWaveHOME (Rx) and BioWaveGO (OTC) and two types of disposables - sterile single use percutaneous electrodes and reusable noninvasive electrodes. More information is available at biowave.com.

Pineapple

Grant in 2019
Pineapple Tech Pty Ltd is a South African company that operates a peer-to-peer insurance platform, providing short-term insurance coverage to its members. Founded in 2017 and based in Johannesburg, the company allows users to pay and track their premiums online while selecting their preferred network for pooling. Pineapple aims to innovate the insurance experience by aligning incentives with users, offering transparency about premium usage, and returning any unused premiums to members. The platform simplifies the insurance process, enabling users to obtain coverage quickly, often in under 60 seconds, by utilizing AI technology. Pineapple launched its "My Stuff" per-item insurance in 2018 and expanded its offerings to include "My Ride" for auto insurance. The company has also formed a partnership with Travelers in the United States and provides a white-labeled version of its platform for that market.

TryCycle Data Systems

Pre Seed Round in 2019
TryCycle Data Systems Inc. is a Canadian technology company founded in 2016, focused on enhancing the treatment of individuals dealing with substance use, addiction, mental health issues, and post-traumatic stress disorders. The company has developed a predictive health technology system that monitors real-time behavior patterns and assesses risk factors associated with relapse. By enabling healthcare professionals to receive regular self-assessments from patients, TryCycle's system serves as an early warning tool that highlights unhealthy behaviors and triggers. This approach aims to bridge the gaps between various treatment providers, facilitating a more integrated support system for patients and allowing practitioners to address those at the highest risk effectively.

Azitra

Series A in 2019
Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

Paygilant

Private Equity Round in 2019
Paygilant Ltd. is a developer of mobile fraud prevention solutions, focusing on online transactions, payments, and money transfer fraud. Founded in 2014 and based in Ramat Gan, Israel, the company addresses the rising challenge of mobile fraud as the adoption of mobile payments increases. Paygilant offers a comprehensive suite of services, including account takeover prevention, new account fraud solutions, and transactional fraud protection. Its patented technology integrates six proprietary intelligence sets to ensure a frictionless user experience while maintaining security and user privacy. The company’s solutions provide end-to-end protection, from app download to ongoing transactions, effectively safeguarding legitimate customers against fraudulent activities in the evolving digital payment landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.